DE69533167D1 - Impfstoffe gegen den hepatitis b und c virus - Google Patents

Impfstoffe gegen den hepatitis b und c virus

Info

Publication number
DE69533167D1
DE69533167D1 DE69533167T DE69533167T DE69533167D1 DE 69533167 D1 DE69533167 D1 DE 69533167D1 DE 69533167 T DE69533167 T DE 69533167T DE 69533167 T DE69533167 T DE 69533167T DE 69533167 D1 DE69533167 D1 DE 69533167D1
Authority
DE
Germany
Prior art keywords
hepatitis
viral genome
virus
disclosed
incomplete
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69533167T
Other languages
English (en)
Inventor
Catherine J Pachuk
Jack Wands
Takaji Wakita
Zurawski, Jr
Leslie R Coney
Katsutoshi Tokushige
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Apollon Inc
Original Assignee
General Hospital Corp
Apollon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26981379&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69533167(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by General Hospital Corp, Apollon Inc filed Critical General Hospital Corp
Application granted granted Critical
Publication of DE69533167D1 publication Critical patent/DE69533167D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
DE69533167T 1994-10-05 1995-10-05 Impfstoffe gegen den hepatitis b und c virus Expired - Lifetime DE69533167D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31824894A 1994-10-05 1994-10-05
US46785995A 1995-06-06 1995-06-06
PCT/US1995/013552 WO1996010997A1 (en) 1994-10-05 1995-10-05 Hepatitis virus vaccines

Publications (1)

Publication Number Publication Date
DE69533167D1 true DE69533167D1 (de) 2004-07-22

Family

ID=26981379

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69533167T Expired - Lifetime DE69533167D1 (de) 1994-10-05 1995-10-05 Impfstoffe gegen den hepatitis b und c virus

Country Status (9)

Country Link
EP (1) EP0789563B8 (de)
JP (1) JPH11501204A (de)
AT (1) ATE269064T1 (de)
AU (1) AU701747B2 (de)
CA (1) CA2202088A1 (de)
DE (1) DE69533167D1 (de)
HU (1) HUT77870A (de)
NZ (1) NZ296304A (de)
WO (1) WO1996010997A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002500502A (ja) 1996-06-11 2002-01-08 メルク エンド カンパニー インコーポレーテッド 合成ｃ型肝炎遺伝子
JP2002125688A (ja) * 2000-10-30 2002-05-08 Tosoh Corp Ｃ型肝炎ウイルスの高感度検出のためのオリゴヌクレオチドおよび検出法
GB0226722D0 (en) * 2002-11-15 2002-12-24 Glaxo Group Ltd Vaccine
CU23496A1 (es) * 2004-09-03 2010-02-23 Ct Ingenieria Genetica Biotech Composición vacunal contra el virus de la hepatitis c

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0485209A1 (de) * 1990-11-08 1992-05-13 Immuno Japan Inc. Mit Non-A Non-B Hepatitis Virus verwandtes Antigen, Aufspürsysteme für Antikörper, Polynukleotide und Polypeptide
JPH0692996A (ja) * 1991-12-28 1994-04-05 Kunitada Shimotoono Ｃ型肝炎ウィルス粒子を構成する蛋白質およびその発現
JP3439209B2 (ja) * 1992-01-31 2003-08-25 アボツト・ラボラトリーズ Ｈｃｖ蛋白のための哺乳動物発現システム
EP0625204B1 (de) * 1992-02-04 2002-06-19 Chiron Corporation Hepatistherapeutikum
JPH06141870A (ja) * 1992-03-12 1994-05-24 Tokyo Met Gov Rinshiyou Igaku Sogo Kenkyusho 非ａ非ｂ型肝炎ウイルス抗原をコードするｄｎａ断片
JPH06279500A (ja) * 1992-09-30 1994-10-04 Imuno Japan:Kk ＨＢｃ融合蛋白粒子およびその製造方法

Also Published As

Publication number Publication date
EP0789563B1 (de) 2004-06-16
AU4006195A (en) 1996-05-02
NZ296304A (en) 1999-06-29
AU701747B2 (en) 1999-02-04
WO1996010997A1 (en) 1996-04-18
JPH11501204A (ja) 1999-02-02
CA2202088A1 (en) 1996-04-18
EP0789563A1 (de) 1997-08-20
HUT77870A (hu) 1998-09-28
ATE269064T1 (de) 2004-07-15
EP0789563B8 (de) 2004-11-17
EP0789563A4 (de) 1998-10-07

Similar Documents

Publication Publication Date Title
CA2283464A1 (en) Functional dna clone for hepatitis c virus (hcv) and uses thereof
ATE335831T1 (de) Nukleinsäurevektor, einen solchen vektor enthaltene verbindung und impfstoff zur immunisierung gegen hepatitis
MXPA02005525A (es) Clones infecciosos.
ATE369384T1 (de) Expression und export von interferon-alpha proteinen als fc fusionsproteine
DE69837708D1 (de) Von alphavirus abgeleitete vektoren als impfstoffe gegen eine paramyxovirusinfektion
RU2003118436A (ru) Модифицированный вариант вируса коровьей оспы ankara
ES2285832T3 (es) Complejo de peptido antigenico-proteina de choque termico modificada.
ATE309367T1 (de) Nukleotid- und aminosäuresequenzen der gene des hüllproteins 1 und des kernproteins von hepatitis c virus
Giantini et al. Reovirus type 3 genome segment S4: nucleotide sequence of the gene encoding a major virion surface protein
Hilleman Immunologic, chemotherapeutic and interferon approaches to control of viral disease
DE69533167D1 (de) Impfstoffe gegen den hepatitis b und c virus
ES2188802T3 (es) Vectores viricos de replicacion condicional y su uso.
WO1996040764A3 (en) Nucleotide and amino acid sequences of hypervariable region 1 of the envelope 2 gene of hepatitis c virus
CU23245A1 (es) CADENAS QUIMéRICAS CODIFICANTES PARA PROTEINAS INDUCTORAS DE EFECTOS CONTRA VIRUS. PREPARADOS UTILIZANDO PROTEINAS QUIMéRICAS
BR9908540A (pt) Molécula de ácido nucleico recombinante, célula hospedeira recombinante, composição farmacêutica, e, processo para induzir uma resposta imune contra vìrus de hepatite c em um humano não infectado por vìrus de hepatite c, para imunizar um humano suscetìvel a vìrus de hepatite c, e para tratar um humano que é infectado com vìrus de hepatite c
BR9508645A (pt) Vacina da peritonite infecciosa felina
WO1998023752A3 (de) Papillomviren, mittel zu deren nachweis sowie zur therapie von durch sie verursachten erkrankungen
RU2202612C2 (ru) к-ДНК ДЛЯ ПОЛУЧЕНИЯ РЕКОМБИНАНТНОГО ВИРУСА КЛЕЩЕВОГО ЭНЦЕФАЛИТА (TBEV)
HUP0103871A2 (hu) Rekombináns CELO-vírus és CELO vírus DNS
TH63069A (th) โคลนก่อการติดเชื้อ
RU97107000A (ru) Вакцины против вирусов гепатита
Morrison mRNA Vaccines and their impact on medicine.
PT1254663E (pt) Agente antiviral
US20040001805A1 (en) Method and compositions for conferring viral immunity and reversing viral pathogenesis via strategic infection with a theravirus thereby providing genomic integration of genetically engineered, replication incompetent, integrating viral DNA
RU93018105A (ru) Штамм рекомбинантного вируса осповакцины, вызывающий иммунитет против вируса венесуэльского энцефаломиелита лошадей в организме животных, и способ его получения

Legal Events

Date Code Title Description
8332 No legal effect for de